{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:43:09Z","timestamp":1761864189756,"version":"3.41.2"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>The purpose of this study was to evaluate the association of diabetes mellitus (DM) with neointimal formation after implantation of second-generation drug-eluting stent (DES) visualized by optical coherence tomography (OCT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients with single de novo coronary artery disease treated with second-generation DES between June 2014 and June 2017 in our department underwent OCT examination at 1-year follow-up and were enrolled in this retrospective study. The primary end point was in-stent mean neointimal thickness (MNT), and secondary end points included uncovered stent strut, minimal lumen area (MLA), neointimal burden, neointimal hyperplasia (NIH) patterns and stent thrombosis (ST) after 1 year of OCT follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 68 patents with DM (DM group) and 216 patients without DM (non-DM group) were enrolled. At 1-year follow-up, the DM group compared with the non-DM group, showed: MNT [160 (85\u2013245) \u03bcm vs. 120 (60\u2013220) \u03bcm, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.038] and neointimal burden [21.4 (8.3\u201330.1)% vs. 14.0 (5.7\u201326.1)%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.023] to be significantly increased. Concurrently, MLA [4.60 (3.53\u20136.06) mm vs. 5.76 (4.28\u20137.20) mm<jats:sup>2<\/jats:sup>, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0. 0.002] was significantly reduced. Interestingly, the degree of uncovered struts (7.3 \u00b1 7.1% vs. 7.7 \u00b1 6.7%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.704), NIH patterns (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.984), and ST (7.9% vs. 7.4%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.88) were comparable between the two groups. After propensity score matching, the MNT [160 (90\u2013240) \u03bcm vs. 110 (60\u2013220) \u03bcm, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.048] and neointimal burden [21.4 (8.3\u201330.1)% vs. 15.4 (5.6\u201326.3)%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.044] remained significantly different in the DM compared to the non-DM group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>DM leads to significant increase in MNT and neointimal burden even with second-generation DES, nevertheless stent strut coverage, ST and NIH characteristics remained comparable among the cohorts at 1-year.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000000964","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T11:23:30Z","timestamp":1602761010000},"page":"105-111","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The association of diabetes mellitus with neointimal formation following deployment of second-generation drug-eluting stents: an optical coherence tomographic study"],"prefix":"10.1097","volume":"32","author":[{"given":"Jin-Zan","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Cardiology, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen"},{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Qi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"},{"name":"Department of Cardiology, Yixing People\u2019s Hospital, Wuxi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"},{"name":"Department of Cardiology, Affiliated Hospital of Nantong University, Nantong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"You","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill D.","family":"Gogas","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"},{"name":"Department of Cardiology, Emory University Hospital, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Bo","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2009.01.054","article-title":"Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry).","volume":"53","author":"Fr\u00f6bert","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.amjcard.2018.02.034","article-title":"Outcomes in patients with diabetes mellitus according to insulin treatment after percutaneous coronary intervention in the second-generation drug-eluting stent era.","volume":"121","author":"Pi","year":"2018","journal-title":"Am J Cardiol"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0003319717735226","article-title":"Impact of diabetes mellitus on percutaneous coronary intervention in Chinese patients: a large single-center data.","volume":"69","author":"Wang","year":"2018","journal-title":"Angiology"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/01.CIR.94.8.1818","article-title":"Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.","volume":"94","author":"Kip","year":"1996","journal-title":"Circulation"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.amjcard.2016.10.038","article-title":"Impact of patient and lesion complexity on long-term outcomes following coronary revascularization with new-generation drug-eluting stents.","volume":"119","author":"Koskinas","year":"2017","journal-title":"Am J Cardiol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/eurheartj\/ehp433","article-title":"Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis.","volume":"31","author":"Prati","year":"2010","journal-title":"Eur Heart J"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcmg.2011.09.015","article-title":"Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging.","volume":"5","author":"Nakano","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","article-title":"Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.","volume":"59","author":"Tearney","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.jcin.2010.08.006","article-title":"Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.","volume":"3","author":"Tanaka","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jcin.2015.02.020","article-title":"Comparison of neoatherosclerosis and neovascularization between patients with and without diabetes: an optical coherence tomography study.","volume":"8","author":"Gao","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2337\/dc18-su09","article-title":"Updates to the standards of medical care in diabetes-2018.","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ahj.2009.06.004","article-title":"Optical coherence tomography patterns of stent restenosis.","volume":"158","author":"Gonzalo","year":"2009","journal-title":"Am Heart J"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/clc.20960","article-title":"Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.","volume":"34","author":"Lee","year":"2011","journal-title":"Clin Cardiol"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MCA.0000000000000072","article-title":"Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses.","volume":"25","author":"Di Vito","year":"2014","journal-title":"Coron Artery Dis"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0735-1097(95)00496-3","article-title":"Potential mechanisms promoting restenosis in diabetic patients.","volume":"27","author":"Aronson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jcmg.2014.05.004","article-title":"Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.","volume":"7","author":"Kim","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/eurheartj\/ehy436","article-title":"Angiographic late lumen loss revisited: impact on long-term target lesion revascularization.","volume":"39","author":"Asano","year":"2018","journal-title":"Eur Heart J"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.ijcard.2013.07.160","article-title":"Optical coherence tomography analysis of strut coverage in biolimus- and sirolimus-eluting stents: 3-month and 12-month serial follow-up.","volume":"168","author":"Kim","year":"2013","journal-title":"Int J Cardiol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2011.10.102","article-title":"Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents.","volume":"166","author":"Takano","year":"2013","journal-title":"Int J Cardiol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1093\/eurheartj\/ehv227","article-title":"The association between in-stent neoatherosclerosis and native coronary artery disease progression: a long-term angiographic and optical coherence tomography cohort study.","volume":"36","author":"Taniwaki","year":"2015","journal-title":"Eur Heart J"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"e1366","DOI":"10.4244\/EIJY15M12_05","article-title":"The impact of in-stent neoatherosclerosis on long-term clinical outcomes: an observational study from the Kobe University Hospital optical coherence tomography registry.","volume":"12","author":"Kuroda","year":"2016","journal-title":"Eurointervention"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2007.04.051","article-title":"Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT matched-cohort registry.","volume":"50","author":"Machecourt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40256-018-0295-y","article-title":"Early and late stent thrombosis in patients with versus without diabetes mellitus following percutaneous coronary intervention with drug-eluting stents: a systematic review and meta-analysis.","volume":"18","author":"Yuan","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.","volume":"115","author":"Finn","year":"2007","journal-title":"Circulation"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4244\/EIJV9I8A157","article-title":"Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomography between subacute and late\/very late thrombosis in the Mechanism Of Stent Thrombosis (MOST) study.","volume":"9","author":"Parodi","year":"2013","journal-title":"Eurointervention"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:07:07Z","timestamp":1753812427000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000964","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}